Contracting&Outsourcing - Rottendorf Pharma as Full Process Owner

ID: 1019702
recent pressrelease next pressrelease

(PresseBox) - In this year for the first time Rottendorf Pharma GmbH presented itself as an internationally recognized CMO and development company on the 9th Annual Contracting & Outsourcing Conference & Tabletop Exhibition held by the Contract Pharma Magazine in New Jersey (USA).
Dirk Meyer, Vice-President Business Development & Sales/Rottendorf Pharma GmbH, is already planning next year's participation: "Companies like Rottendorf stand out from the crowd. Rottendorf is not a standard CMO but is process owner of the products that we develop and produce. The feedback of our customers confirms our commitment. We will attract further important customers in the USA."
At the Conference, which took place from September 23 - 24, 2010, about 160 pharmaceutical companies presented their manufacturing, packaging and analytics portfolios during the one-day exhibition. The range of services of Rottendorf as an independent, medium-sized company met great interest. The pharmaceutical company offers complete full service solutions with its three core competences: contract manufacturing, contract packaging and contract development of solid dosage forms.

Rottendorf Pharma is one of the leading pharmaceutical contract manufacturers for development, production and packaging of solid dosage forms in Europe. Besides the two sites in Germany the company is also represented by a subsidiary, Rottendorf Pharma S.A.S., in Valenciennes/France.
Rottendorf Pharma belongs to a nonprofit foundation and focuses not only on market success but also on social engagement.
For its 150 customers, among them a lot of the biggest Big Pharma companies, Rottendorf is an exclusive service provider who offers a maximum of production reliability and investment security in addition to modern production facilities and high potency technologies. Audited and approved by the internationally recognized FDA, the company is not only qualified for the European but also for the US market. Moreover, Rottendorf is optimally positioned for future challenges due to annual investments of several million Euros in the modernization and expansion of the facilities and technologies. In addition to contract manufacturing and contract packaging, the development of processes and formulations plays a decisive role in the future company strategy.





Keywords (optional):



Company information / Profile:

Rottendorf Pharma is one of the leading pharmaceutical contract manufacturers for development, production and packaging of solid dosage forms in Europe. Besides the two sites in Germany the company is also represented by a subsidiary, Rottendorf Pharma S.A.S., in Valenciennes/France.
Rottendorf Pharma belongs to a nonprofit foundation and focuses not only on market success but also on social engagement.
For its 150 customers, among them a lot of the biggest Big Pharma companies, Rottendorf is an exclusive service provider who offers a maximum of production reliability and investment security in addition to modern production facilities and high potency technologies. Audited and approved by the internationally recognized FDA, the company is not only qualified for the European but also for the US market. Moreover, Rottendorf is optimally positioned for future challenges due to annual investments of several million Euros in the modernization and expansion of the facilities and technologies. In addition to contract manufacturing and contract packaging, the development of processes and formulations plays a decisive role in the future company strategy.

PressRelease by

Requests:



PressContact / Agency:



published by: PresseBox
print pressrelease  send to a friend  

Date: 10/25/2010 - 08:02
Language: English
News-ID 1019702
Character count: 0
Kontakt-Informationen:
Firma: Rottendorf Pharma GmbH
Ansprechpartner: Feedback to businesspress24.com about Pressrelease-id:
Stadt: Ennigerloh
Telefon:

Comments:



Number of hits: 172

Linking-Tips:



Direct Link to this PressRelease:






We would appreciate a link in your News-, Press- or Partner-Site.

Comments on this PressRelease






All members: 9 438
Register today: 0
Register yesterday: 0
Members online: 0
Guests online: 58


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.

Categories:


[ more PressReleases ][ RSS-Feed ]